Park K - Search Results

1

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.

Veillon R, Sakai H, Le X, Felip E, Cortot AB, Smit EF, Park K, Griesinger F, Britschgi C, Wu YL, Melosky B, Baijal S, Jr GC, Sedova M, Berghoff K, Otto G, Paik PK. Veillon R, et al. Among authors: park k. Clin Lung Cancer. 2022 Jun;23(4):320-332. doi: 10.1016/j.cllc.2022.03.002. Epub 2022 Mar 17. Clin Lung Cancer. 2022. PMID: 35466070 Free PMC article.

2

A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.

Park J, Ahn YC, Kim H, Lee SH, Park SH, Lee KE, Lim DH, Park J, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K. Park J, et al. Among authors: park sh, park k. Lung Cancer. 2003 Nov;42(2):227-35. doi: 10.1016/s0169-5002(03)00282-4. Lung Cancer. 2003. PMID: 14568691 Clinical Trial.

3

Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer.

Park J, Park BB, Kim JY, Lee SH, Lee SI, Kim HY, Kim JH, Park SH, Lee KE, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K. Park J, et al. Among authors: park bb, park ys, park sh, park jo, park k. Clin Cancer Res. 2004 Jul 1;10(13):4383-8. doi: 10.1158/1078-0432.CCR-04-0189. Clin Cancer Res. 2004. PMID: 15240526

4

Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?

Park BB, Park JO, Kim H, Ahn YC, Choi YS, Kim K, Kim J, Shim YM, Ahn JS, Park K. Park BB, et al. Among authors: park jo, park k. Lung Cancer. 2006 Sep;53(3):323-30. doi: 10.1016/j.lungcan.2006.05.024. Epub 2006 Jul 17. Lung Cancer. 2006. PMID: 16844258

5

Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.

Park S, Ahn MJ, Ahn JS, Lee J, Hong YS, Park BB, Lee SC, Hwang IG, Park JO, Lim H, Kang WK, Park K. Park S, et al. Among authors: park bb, park jo, park k. Lung Cancer. 2007 Oct;58(1):116-22. doi: 10.1016/j.lungcan.2007.05.022. Epub 2007 Jul 12. Lung Cancer. 2007. PMID: 17624473

6

Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment.

Park MJ, Lee J, Hong JY, Choi MK, Yi JH, Lee SJ, Oh SJ, Ahn JS, Park K, Ahn MJ. Park MJ, et al. Among authors: park k. Cancer. 2009 Apr 1;115(7):1518-30. doi: 10.1002/cncr.24151. Cancer. 2009. PMID: 19177485 Free article.

7

Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer.

Chang MH, Kim KH, Jun HJ, Kim HS, Yi SY, Uhm JE, Park MJ, Lim DH, Ji SH, Hwang IG, Lee J, Park YH, Ahn JS, Ahn MJ, Park K. Chang MH, et al. Among authors: park yh, park mj, park k. Cancer Chemother Pharmacol. 2009 Oct;64(5):917-24. doi: 10.1007/s00280-009-0943-7. Epub 2009 Feb 17. Cancer Chemother Pharmacol. 2009. PMID: 19221753 Clinical Trial.

8

Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group.

Uhm JE, Park BB, Ahn MJ, Lee J, Ahn JS, Kim SW, Kim HT, Lee JS, Kang JH, Cho JY, Song HS, Park SH, Sohn CH, Shin SW, Choi JH, Park K. Uhm JE, et al. Among authors: park bb, park sh, park k. J Thorac Oncol. 2009 Sep;4(9):1136-43. doi: 10.1097/JTO.0b013e3181b270a7. J Thorac Oncol. 2009. PMID: 19687764 Free article. Clinical Trial.

9

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.

Lee DH, Kim SW, Suh C, Lee JS, Ahn JS, Ahn MJ, Park K, Na II, Lee JC, Ryoo BY, Yang SH. Lee DH, et al. Among authors: park k. Cancer. 2010 Jan 1;116(1):132-6. doi: 10.1002/cncr.24719. Cancer. 2010. PMID: 19904804 Free article. Clinical Trial.

10

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer.

Chang MH, Ahn JS, Lee J, Kim KH, Park YH, Han J, Ahn MJ, Park K. Chang MH, et al. Among authors: park yh, park k. Lung Cancer. 2010 Sep;69(3):323-9. doi: 10.1016/j.lungcan.2009.12.002. Epub 2010 Jan 12. Lung Cancer. 2010. PMID: 20061047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23,673 results

Search Page